Markers of Primary Chemoresistance of Epithelial Ascites Cells in Patients with Ovarian Cancer Guidelines for Practitioners
Determined the primary chemoresistance markers (expression of genes ERCC1, TOP2a and ABCB1) in epithelial cells of ascites 32 primary patients with verified ovarian cancer using RT-PCR. After standard chemotherapy by the AR scheme (cisplatin+doxoru-bicin), the relapse-free survival of patients was a...
Saved in:
Main Authors: | D. R. Dolgova, T. P. Gening, T. V. Abakumova, S. O. Gening, I. I. Antoneeva, A. B. Pescov, A. Yu. Fedotova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC "Publishing House OKI"
2020-05-01
|
Series: | Антибиотики и Химиотерапия |
Subjects: | |
Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/137 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IL-8 and WISP1 in the molecular characteristics of malignant ascites in ovarian cancer
by: T. V. Abakumova, et al.
Published: (2024-07-01) -
Parameters of the glutathione system and thioredoxin in blood plasma and ascites and GSTP1 Ile105Val gene polymorphism as factors of resistance to platinum-containing chemotherapy in ovarian cancer patients
by: D. R. Dolgova, et al.
Published: (2021-01-01) -
Ascitis as a unique microenvironment of tumors in ovarian cancer: interaction with prognosis and chemoresistance
by: A. B. Villert, et al.
Published: (2019-07-01) -
Ascites as a subject of studies in ovarian cancer
by: A. B. Villert, et al.
Published: (2019-02-01) -
EXPERIENCE WITH INTRAPERITONEAL CHEMOTHERAPY USING ASCITIC FLUID AS A SOLVENT OF CHEMICALS IN THE TREATMENT OF OVARIAN CANCER
by: Yu. S. Sidorenko, et al.
Published: (2014-09-01)